Flaxseed supplementation significantly reduces hemoglobin A1c in patients with type 2 diabetes mellitus: A systematic review and meta-analysis
H Xi, W Zhou, M Sohaib, Y Niu, R Zhu, Y Guo, S Wang… - Nutrition Research, 2023 - Elsevier
Flaxseed is a functional food because of its high content of alpha-linolenic acid, lignans, and
dietary fiber. We hypothesized that flaxseed supplementation would improve …
dietary fiber. We hypothesized that flaxseed supplementation would improve …
[HTML][HTML] Decreasing trend of blood lipid profile in type 2 diabetes: Not a promising change in HDL-C, a serial cross-sectional study
Background The prevalence of dyslipidemia in patients with type 2 diabetes (T2D) has been
reported to be relatively high. The current study aimed to investigate the trend of serum lipid …
reported to be relatively high. The current study aimed to investigate the trend of serum lipid …
[HTML][HTML] Lipid Disorders Management Strategies (2024) in Prediabetic and Diabetic Patients
Dyslipidaemia is a modifiable risk factor commonly associated with diabetes mellitus and
prediabetes, with a major impact on the early development of atherosclerotic cardiovascular …
prediabetes, with a major impact on the early development of atherosclerotic cardiovascular …
[HTML][HTML] High triglyceride levels increase the risk of diabetic microvascular complications: a cross-sectional study
J Li, L Shi, G Zhao, F Sun, Z Nie, Z Ge, B Gao… - Lipids in Health and …, 2023 - Springer
Background The prevalence of microvascular complications in type 2 diabetes mellitus
(T2DM) is increasing. The effect of lipid profiles on diabetic microvascular complications …
(T2DM) is increasing. The effect of lipid profiles on diabetic microvascular complications …
The association of dyslipidemia with kidney stone: result from the NHANES 2007–2020
M Gao, M Liu, Z Zhu, H Chen - International Urology and Nephrology, 2024 - Springer
Objective To examine the association between dyslipidemia and kidney stone disease
(KSD). Methods A cross-sectional study data from 2007 to 2020 National Health and …
(KSD). Methods A cross-sectional study data from 2007 to 2020 National Health and …
Evaluating Preferences of Hospitalized Diabetes Patients for Hospital‐Wide Glycemic Control Programme: A Discrete Choice Experiment
J Dai, T He, X He, H Li, L Li, J Sun… - Journal of Diabetes …, 2024 - Wiley Online Library
Background: Effective glycemic control is crucial for hospitalized patients, leading to benefits
such as shorter hospital stays and reduced postoperative infection rates. While previous …
such as shorter hospital stays and reduced postoperative infection rates. While previous …
[HTML][HTML] Efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a double-blind …
Methods The Peptide Innovation for Early Diabetes Treatment (PIONEER) 11 trial was a
double-blind, randomised, Phase IIIa trial conducted across 52 sites in the China region …
double-blind, randomised, Phase IIIa trial conducted across 52 sites in the China region …
[HTML][HTML] Prevalence and patterns of dyslipidemia among lipid-lowering drug-naïve patients with type 2 diabetes mellitus–A countrywide study in Bangladesh
ABM Kamrul-Hasan, MS Alam, N Zarin… - … and Metabolic Science, 2023 - Elsevier
Background Dyslipidemia is a major risk factor for cardiovascular disease in patients with
type 2 diabetes mellitus (T2DM). This countrywide study explored the prevalence and …
type 2 diabetes mellitus (T2DM). This countrywide study explored the prevalence and …
Association of the systemic immuno-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio with diabetic microvascular complications
J Li, X Wang, W Jia, K Wang, W Wang… - Frontiers in …, 2024 - frontiersin.org
Background The systemic immuno-inflammation index (SII), neutrophil-to-lymphocyte ratio
(NLR), and platelet-to-lymphocyte ratio (PLR) are widely used and have been shown to be …
(NLR), and platelet-to-lymphocyte ratio (PLR) are widely used and have been shown to be …
[HTML][HTML] Status of lipid control in Bangladeshi subjects with type 2 diabetes mellitus on lipid-lowering drugs: a multicenter, facility-based, cross-sectional study
S Selim, MS Alam, SK Talukder, ML Kabir… - BMC Endocrine …, 2023 - Springer
Background Achievement of lipid targets is crucial in patients with type 2 diabetes mellitus
(T2DM) to mitigate the risk of cardiovascular diseases (CVD). Data on lipid-control status …
(T2DM) to mitigate the risk of cardiovascular diseases (CVD). Data on lipid-control status …